| ||||||||||||||
|
|
|||||||||||||

*Department of Anesthesiology, Perioperative and Pain Medicine, and
Allergy and Clinical Immunology Training Program, Department of Medicine, Brigham and Womens Hospital, Harvard Medical School, Boston, Massachusetts
Address correspondence and reprint requests to David L. Hepner, MD, Department of Anesthesiology, Perioperative and Pain Medicine, Brigham and Womens Hospital, Harvard Medical School, 75 Francis St., Boston, MA 02115. Address e-mail to dhepner{at}partners.org
Anesthesiologists use a myriad of drugs during the provision of an anesthetic. Many of these drugs have side effects that are dose related, and some lead to severe immune-mediated adverse reactions. Anaphylaxis is the most severe immune-mediated reaction; it generally occurs on reexposure to a specific antigen and requires the release of proinflammatory mediators. Anaphylactoid reactions occur through a direct non-immunoglobulin E-mediated release of mediators from mast cells or from complement activation. Muscle relaxants and latex account for most cases of anaphylaxis during the perioperative period. Symptoms may include all organ systems and present with bronchospasm and cardiovascular collapse in the most severe cases. Management of anaphylaxis includes discontinuation of the presumptive drug (or latex) and anesthetic, aggressive pulmonary and cardiovascular support, and epinephrine. Although a serum tryptase confirms the diagnosis of an anaphylactic reaction, the offending drug can be identified by skinprick, intradermal testing, or serologic testing. Prevention of recurrences is critical to avoid mortality and morbidity.
This article has been cited by other articles:
![]() |
L. Meng and E. L. Williams Case report: Treatment of rocuronium-induced anaphylactic shock with vasopressin: [Presentation de cas: traitement d'un choc anaphylactique provoque par le rocuronium avec de la vasopressine] Can J Anesth, July 1, 2008; 55(7): 437 - 440. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Parlow and J. M. van Vlymen The methylene blues: anticipating adverse reactions to non-anesthetic drugs/Le blues du methylene : prevenir les reactions indesirables aux medicaments non anesthesiques Can J Anesth, January 1, 2008; 55(1): 1 - 5. [Full Text] [PDF] |
||||
![]() |
W. Dietrich, A. Ebell, R. Busley, and A.-L. Boulesteix Aprotinin and Anaphylaxis: Analysis of 12,403 Exposures to Aprotinin in Cardiac Surgery Ann. Thorac. Surg., October 1, 2007; 84(4): 1144 - 1150. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Cummings III and K. Arnaut Case report: Fentanyl-associated intraoperative anaphylaxis with pulmonary edema: [Etude de cas : Anaphylaxie peroperatoire avec oedeme pulmonaire associe au fentanyl] Can J Anesth, April 1, 2007; 54(4): 301 - 306. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Hall, E. Frigas, D. Matesic, M. D. Gillett, and J. Sprung Case report: Intraoperative anaphylactoid reaction and hydroxyethyl starch in balanced electrolyte solution (Hextend(R)): [Presentation de cas : reaction anaphylactoide peroperatoire et amidon hydroxyethyle dans une solution d'electrolyte balancee (Hextend(R))]. Can J Anesth, October 1, 2006; 53(10): 989 - 993. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Ritchey, R. F. Helfand, S. A. Irefin, M. Argalious, and J. E. Tetzlaff Hetastarch Allergy and Positive Latex Radioallergosorbent Test in a Patient Suffering Cardiovascular Decompensation During Multiple Perioperative Periods Anesth. Analg., December 1, 2005; 101(6): 1709 - 1712. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. McBrien, S. T. Webb, D. S. Breslin, A. D. Axon, and J. M. Hunter Anaphylaxis and anaesthesia Br. J. Anaesth., April 1, 2005; 94(4): 547 - 548. [Full Text] [PDF] |
||||
![]() |
W. J. Russell Anaphylaxis Is Not a Dose/Response Effect Anesth. Analg., February 1, 2005; 100(2): 597 - 598. [Full Text] [PDF] |
||||
![]() |
W. J. Russell Cross-Reactivity Documented for Hemaccel and Gelofusin Anesth. Analg., May 1, 2004; 98(5): 1499 - 1499. [Full Text] [PDF] |
||||
![]() |
J. V. Roth and A. Shields A Dilemma: How Does One Treat Anaphylaxis in the Sulfite Allergic Patient Since Epinephrine Contains Sodium Metabisulfite? Anesth. Analg., May 1, 2004; 98(5): 1499 - 1499. [Full Text] [PDF] |
||||
![]() |
D. S. Breslin, M. E. McBrien, and D. L. Hepner Management of Severe Anaphylactic Reactions Should Include Administration of Alpha Adrenergic Agonists * Response Anesth. Analg., May 1, 2004; 98(5): 1499 - 1500. [Full Text] [PDF] |
||||
|